Next Article in Journal
Research on the Energy Transfer Law of Polymer Gel Profile Control Flooding in Low-Permeability Oil Reservoirs
Previous Article in Journal
Multilayered Tissue Assemblies Through Tuneable Biodegradable Polyhydroxyalkanoate Polymer (Mesh)-Reinforced Organ-Derived Extracellular Matrix Hydrogels
Previous Article in Special Issue
Mechanically Strong and Flame-Retardant Cellulose-Based Aerogel Prepared via Phosphorylation-Coupled Ca2+ Coordination
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering

1
Department of Bioengineering, Universidad Carlos III de Madrid (UC3M), 28911 Madrid, Spain
2
Department of Electronic Technology, Universidad Carlos III de Madrid (UC3M), 28911 Madrid, Spain
3
Department of Applied Macromolecular Chemistry, Institute of Polymer Science and Technology, Spanish National Research Council (ICTP-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
4
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain
5
Group of Organic Synthesis and Bioevaluation, Instituto Pluridisciplinar, Universidad Complutense de Madrid (UCM), Associated Unit to the ICTP-IQM-CSIC, Paseo Juan XXIII, nº 1, 28040 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Gels 2025, 11(7), 540; https://doi.org/10.3390/gels11070540
Submission received: 31 May 2025 / Revised: 27 June 2025 / Accepted: 4 July 2025 / Published: 11 July 2025

Abstract

Plasma-derived fibrin hydrogels are widely used in tissue engineering because of their excellent biological properties. Specifically, human plasma-derived fibrin hydrogels serve as 3D matrices for autologous skin graft production, skeletal muscle repair, and bone regeneration. Nevertheless, for advanced applications such as in vitro skin equivalents and engineered grafts, the intrinsic limitations of native fibrin hydrogels in terms of long-term mechanical stability and resistance to degradation need to be addressed to enhance the usefulness and application of these hydrogels in tissue engineering. In this study, we chemically modified plasma-derived fibrin by incorporating succinimidyl alginate (SA), a version of alginate chemically modified to introduce reactive succinimidyl groups. These NHS ester groups (N-hydroxysuccinimide esters), attached to the alginate backbone, are highly reactive toward the primary amine groups present in plasma proteins such as fibrinogen. When mixed with plasma, the NHS groups covalently bond to the amine groups in fibrin, forming stable amide linkages that reinforce the fibrin network during hydrogel formation. This chemical modification improved mechanical properties, reduces contraction, and enhanced the stability of the resulting hydrogels. Hydrogels were prepared with a final fibrinogen concentration of 1.2 mg/mL and SA concentrations of 0.5, 1, 2, and 3 mg/mL. The objective was to evaluate whether this modification could create a more stable matrix suitable for supporting skin tissue development. The mechanical and microstructure properties of these new hydrogels were evaluated, as were their biocompatibility and potential to create 3D skin models in vitro. Dermo-epidermal skin cultures with primary human fibroblast and keratinocyte cells on these matrices showed improved dermal stability and better tissue structure, particularly SA concentrations of 0.5 and 1 mg/mL, as confirmed by H&E (Hematoxylin and Eosin) staining and immunostaining assays. Overall, these results suggest that SA-functionalized fibrin hydrogels are promising candidates for creating more stable in vitro skin models and engineered skin grafts, as well as for other types of engineered tissues, potentially.
Keywords: fibrin hydrogels; plasma-derived fibrin hydrogel; succinimidyl alginate; tissue engineering; dermo-epidermal equivalents; in vitro human skin tissue engineering fibrin hydrogels; plasma-derived fibrin hydrogel; succinimidyl alginate; tissue engineering; dermo-epidermal equivalents; in vitro human skin tissue engineering

Share and Cite

MDPI and ACS Style

Matesanz, A.; Sanz-Horta, R.; Gallardo, A.; Quílez, C.; Reinecke, H.; Acedo, P.; Velasco, D.; Martínez-Campos, E.; Jorcano, J.L.; Elvira, C. Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels 2025, 11, 540. https://doi.org/10.3390/gels11070540

AMA Style

Matesanz A, Sanz-Horta R, Gallardo A, Quílez C, Reinecke H, Acedo P, Velasco D, Martínez-Campos E, Jorcano JL, Elvira C. Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels. 2025; 11(7):540. https://doi.org/10.3390/gels11070540

Chicago/Turabian Style

Matesanz, Ana, Raúl Sanz-Horta, Alberto Gallardo, Cristina Quílez, Helmut Reinecke, Pablo Acedo, Diego Velasco, Enrique Martínez-Campos, José Luis Jorcano, and Carlos Elvira. 2025. "Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering" Gels 11, no. 7: 540. https://doi.org/10.3390/gels11070540

APA Style

Matesanz, A., Sanz-Horta, R., Gallardo, A., Quílez, C., Reinecke, H., Acedo, P., Velasco, D., Martínez-Campos, E., Jorcano, J. L., & Elvira, C. (2025). Succinimidyl Alginate-Modified Fibrin Hydrogels from Human Plasma for Skin Tissue Engineering. Gels, 11(7), 540. https://doi.org/10.3390/gels11070540

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop